Tissue xenografts as a model system for study of the pathogenesis of papillomaviruses

Clinics in Dermatology

Volumn 15, Issue 2, 1997, Pages 229-236

  Howett, Mary K ^a,b   Christensen, Neil D ^a   Kreider, John W ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; CONDYLOMA; HUMAN; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; REVIEW; SCID MOUSE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DYSPLASIA; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; WART VIRUS; XENOGRAFT;

EID: 0030980818     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(96)00166-6     Document Type: Article

References (53)

1. Flanagan SP. "Nude," a new hairless gene with pleiotropic effects in the mouse. Genet Res 1966;8:294-302.
2. Pantelouris EM. Absence of thymus in a mouse mutant. Nature 1968;217:370-80.
3. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301:527-30.
4. DeVillers EM. Human pathogenic papillomavirus types: an update. Current Topics in Microbiology and Immunology 1994;186:1-12.
5. Howley PM. Papillomavirinae: The viruses and their replication. In: Fields BN, Knipe DM, Howley PM, editors. Virology. Philadelphia: Lippincott-Raven, 1996: 2045-76.
6. Shah KV, Howley PM. The papillomaviruses. In: Fields BN, Knipe DM, Howley PM, editors. Virology. Philadelphia: Lippincott-Raven, 1996: 2077-110.
7. Meisels A, Fortin R. Condylomatous lesions of the cervix and vagina. I. cytologic patterns. Acta Cytol 1976;20: 505-9.
8. Meisels A, Fortin R, Roy M. Condylomatous lesions of the cervix. II. Cytologic, colposcopic and histopathologic study. Acta Cytol 1977;21:379-90.
9. Ciuffo G. Imnfesto positivo con filtrato di verruca volgare. Giorn Ital Mal Venereol 1907;48:12-7.
10. Taichman LB, Breitburd F, Croissant O, et al. The search for a culture system for papillomavirus. J Invest Dermatol 1984;83:2s-6s.
11. Kreider JW, Howett MK, Wolfe SA, et al. Morphological transformation in vivo of human uterine cervix with papillomavirus condylomata acuminata. Nature 1985;317:639-41.
12. Kreider JW, Howett MK, Lill NL, et al. In vivo transformation of human skin with human papillomavirus type 11 from condylomata acuminata. J Virol 1986;59:369-76.
13. Kreider JW, Howett MK, Leure-Dupree AE, et al. Laboratory production in vivo of infectious human papillomavirus type 11. J Virol 1987;61:590-3.
14. Kreider JW, Howett MK, Stoler MH, et al. Susceptibility of various human tissues to transformation in vivo with human papillomavirus type 11. Int J Cancer 1988;39:459-65.
15. Dollard SC, Chow LT, Kreider JW, et al. Characterization of an HPV type 11 isolate propagated in human foreskin implants in nude mice. Virology 1989;171:294-7.
16. Bonnez W, Rose RC, Reichman RC. Antibody-mediated neutralization of human papillomavirus type 11 (HPV 11) infection in the nude mouse: Detection of HPV 11 mRNAs. J Inf Diseases 1992;165:376-80.
17. Bonnez W, Rose RC, DaRin C, et al. Propagation of human papillomavirus type 11 in human xenografts using the severe combined immunodeficiency (SCID) mouse and comparison to the nude mouse model. Virology 1993;197: 455-8.
18. Bonnez W, Rose RC, Borkhuis C, et al. Evaluation of temperature sensitivity of human papillomavirus type 11 by using the human xenograft severe combined immunodeficiency mouse model. J Clin Microbiol 1994; 32:1575-7.
19. Stoler MH, Whitbeck A, Wolinsky SM, et al. Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice. J Virol 1990;64:3310-8.
20. Chow LT, Nasseri M, Wolinsky SM, et al. Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J Virol 1987;61:2581-8.
21. Cockley KD, Dolan E, Hendrickson W, et al. Analysis of human papillomavirus type 11 (HPV 11)-specific mRNA synthesis in HPV-infected human tissue in vivo. In: Howley PM, Broker TR, editors. Papillomaviruses. New York: Wiley-Liss, 1990: 393-403.
22. Bonnez W, DaRin C, Rose RC, et al. Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condylomata acuminata. J Gen Virol 1991;72:1343-7.
23. Brown DR, Chin MT, Strike DG. Identification of human papillomavirus type 11 E4 gene products in human tissue implants from athymic mice. Virology 1988;165: 262-7.
24. Brown DR, Fan L, Jones J, et al. Colocalization of human papillomavirus type 11 E1∧E4 and L1 proteins in human foreskin implants grown in athymic mice. Virology 1994; 201:46-54.
25. Brown DR, Bryan JT, Pratt L, et al. Human papillomavirus type 11 E1∧E4 and L1 proteins colocalize in the mouse xenograft system at multiple time points. Virology 1995; 214:259-63.
26. Dartmann K, Schwarz E, Gissmann L, et al. Virology 1986; 151:124-30.
27. Rotenberg MO, Chow LT, Broker TR. Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction. Virology 1989;172:489-97.
28. Kreider JW, Patrick SD, Cladel N, et al. Experimental infection with human papillomavirus type 1 of human hand and foot skin. Virology 1990;177:415-7.
29. Brandsma JL, Brownstein DG, Xiao W, et al. Papilloma formation in human foreskin xenografts after inoculation with human papillomavirus type 16 DNA. J Virol 1995; 69:2716-9.
30. Dollard SC, Wilson JL, Demeter LM, et al. Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. Genes Dev 1992;6: 1131-42.
31. Meyers C, Frattini MG, Hudson JB, et al. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 1992;257:971-3.
32. Bedell MA, Hudson JB, Golub TR, et al. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J Virol 1991;65:2254-60.
33. Sterling J, Stanley M, Gatward G, et al. Production of human papillomavirus type 16 virions in a keratinocyte cell line. J Virol 1995;64:6305-7.
34. Stanley MA, Browne HM, Appleby M, et al. Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer 1989;43:672-6.
35. Olson C. Cutaneous papillomatosis in cattle and other animals. Ann NY Acad Sci 1963;108:1042-56.
36. Jarrett WFH, O'Neil BW, Gaukroger JM, et al. Studies on vaccination against papillomaviruses: a comparison of purified virus, tumor extract and transformed cells in prophylactic vaccination. Vet Rec 1990;126:449-52.
37. Shope RE, Hurst EW. Infectious papillomatosis of rabbits. With a note on histopathology. J Exp Med 1933;58: 607-12.
38. Dvoretzky I, Shober R, Chattopadhyay SK, et al. A quantitative in vitro focus assay for bovine papillomavirus. Virology 1980;103:369-73.
39. Christensen ND, Kreider JW. Antibody-mediated neutralization in vivo of infectious papillomaviruses. J Virol 1990; 64:3151-6.
40. Christensen ND, Hopfl R, DiAngelo SL, et al. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titers of neutralizing antibodies. J Gen Virol 1994;75:2271-6.
41. Rose RC, Reichman RC, Bonnez W. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. J Gen Virol 1994;75: 2075-9.
42. Christensen ND, Kreider JW, Cladel NM, et al. Monoclonal antibody mediated neutralization of infectious human papillomavirus type 11. J Virol 1990;64:5678-81.
43. Christensen ND, Kreider JW, Shah KV, et al. Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions. J Gen Virol 1992;73: 1261-7.
44. Ghim S, Christensen ND, Kreider JW, et al. Comparison of neutralization of BPV-1 infection of C127 cells and bovine fetal skin xenografts. Int J Cancer 1991;49:285-9.
45. Gaukroger J, Bradley A, O'Neil B, et al. Induction of virus-producing tumours in athymic nude mice by bovine papillomavirus type 4. Vet Rec 1989;125:391-2.
46. Christensen ND, Cladel NM, Reed CA, et al. Laboratory production of infectious stocks of rabbit oral papillomavirus. J Gen Virol 1996;77:1793-8.
47. Sexton CJ, Williams AT, Topley P, et al. Development and characterization of a novel xenograft model permissive for human papillomavirus DNA amplification and late gene expression. J Gen Virol 1995;76:3107-12.
48. Christensen ND, Kreider JW. Neutralization of CRPV infectivity by monoclonal antibodies that identify conformational epitopes of intact virions. Virus Res 1991;21:169-79.
49. Roden RBS, Kimbauer R, Jenson AB, et al. Interaction of papillomaviruses with the cell surface. J Virol 1994;8:7260-6.
50. Ludmerer SW, Benincasa D, Mark GE III. Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11. J Virol 1996;70:4791-4.
51. Smith LH, Foster C, Hitchcock ME, et al. Titration of HPV infectivity and antibody neutralization can be measured in vitro. J. Invest. Dermatol. 1995;105:438-44.
52. Angell MG, Christensen ND, Kreider JW. An in vitro system for studying the initial stages of cottontail rabbit papillomavirus contains antibody inducing neutralizing epitopes. Virology 1991;181:572-9.
53. Kreider JW, Christensen ND. Model systems for the treatment of human papillomavirus infections in athymic mice. In: Biswal N, Dempsey WL, Lard SL, et al, eds. Proceedings of the First Workshop on Antiviral Claims for Topical Antiseptics. FDA, U.S. Government, 1994:99-106.